DocDollars

Alkermes, Inc.

MA · United States · Reporting entity ID 100000000255

Total reported 2019–2025
$178.3M
#64 of 2,960 reporting companies — 0.2% of all reported industry payments
$73.6M in general payments across 478,407 records, plus $104.7M in research funding across 22,504 records.

How it breaks down

General payments $73,590,913
Research funding $104,715,338

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Alkermes, Inc. reported $178.3M to US doctors and teaching hospitals from 2019 to 2025, ranking #64 of 2,960 reporting companies. 59% of that was research funding and 41% general payments such as consulting, speaking, food and travel. 478,407 general payment records and 22,504 research records were filed.

Common questions about Alkermes, Inc.

How much has Alkermes, Inc. paid US doctors?

Alkermes, Inc. reported $178,306,251 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $73,590,913 in general payments, $104,715,338 in research funding.

How does Alkermes, Inc. rank among drug and device companies?

It ranks #64 of 2,960 reporting entities by total reported value, about 0.2% of all industry payments in the dataset.

Does a payment from Alkermes, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.